HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to...

Area of Science:

• Cardiovascular Science
• Metabolic Research
• Translational Medicine

Background:

• Atherosclerosis involves LDL-cholesterol accumulation in lesions.
• Macrophages become cholesterol-loaded during atherogenesis.
• Macrophage reverse cholesterol transport (RCT) is key to preventing lesion development.

Purpose of the Study:

• To compare and critically analyze RCT mechanisms in mice and humans.
• To translate in vivo findings into practical concepts for therapy development.
• To identify strategies for preventing lesion development and promoting regression.

Main Methods:

• Review of existing literature on reverse cholesterol transport.
• Comparative analysis of RCT pathways in mouse models and human studies.
• In vivo mechanistic studies of cholesterol efflux and excretion.

Main Results:

• Significant differences exist in RCT steps between mouse models and humans.
• Mouse models offer valuable insights but require careful translation to human physiology.
• Understanding species-specific differences is crucial for effective HDL-targeted therapies.

Conclusions:

• Macrophage RCT is a critical therapeutic target for atherosclerosis.
• Translating mouse model findings to humans necessitates careful consideration of species differences.
• Further research is needed to optimize HDL-targeted therapies for cardiovascular disease prevention.